Related Experiment Video
Updated: Mar 13, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014
Sheryl A Zelenitsky1,2, Jacy Howarth3, Philippe Lagacé-Wiens4,2
1College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada zelenits@umanitoba.ca.
Abstract:
♦ BACKGROUND: Information related to the microbiology of peritonitis is critical to the optimal management of patients receiving peritoneal dialysis (PD). The goal was to characterize the microbiological etiology and antimicrobial susceptibilities of PD-related peritonitis (PDRP) from 2005 to 2014, inclusive. ♦ METHODS: The distribution of organisms in culture-positive PDRP was described for new episodes and relapse infections, and further detailed for monomicrobial and polymicrobial peritonitis. Annual and overall rates of PDRP were also characterized. Antimicrobial susceptibility rates were calculated for the most common and significant organisms. ♦ RESULTS: We identified 539 episodes of PDRP including 501 new and 38 relapse infections. New episodes of peritonitis were associated with a single organism in 85% of cases, and 44% of those involved staphylococci. Polymicrobial PDRP was more likely to involve gram-negative organisms, observed in 58% versus 24% of monomicrobial infections. Antimicrobial resistance was relatively stable from 2005 to 2014. Methicillin resistance was present in 57% of Staphylococcus epidermidis and 20% of other coagulase-negative staphylococci. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for only 11% of S. aureus peritonitis compared with 2% in our previous study of PDRP from 1991 to 1998. Ciprofloxacin resistance in Escherichia coli increased from 3% in our previous study to 24% in 2005 - 2014. ♦ CONCLUSIONS: This study characterizes important differences in the distribution of organisms in new episodes of PDRP and relapse infections, as well as monomicrobial versus polymicrobial peritonitis. It also shows relatively stable rates of antimicrobial resistance from 2005 to 2014, but some increases compared with our previous study.
Insights
This study analyzes 539 cases of peritoneal dialysis-related peritonitis (PDRP) from 2005-2014. It found distinct microbial patterns in new versus relapse infections and stable antimicrobial resistance, with some concerning increases in specific bacteria.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Peritonitis is a serious complication for patients on peritoneal dialysis (PD).
- Understanding the microbiology of PD-related peritonitis (PDRP) is crucial for effective patient management.
- This study aimed to update knowledge on PDRP etiology and antimicrobial susceptibility from 2005-2014.
Purpose of the Study:
- To characterize the microbiological causes of PDRP over a decade (2005-2014).
- To analyze antimicrobial resistance patterns in common PDRP pathogens.
- To compare findings with previous PDRP studies.
Main Methods:
- Retrospective analysis of 539 culture-positive PDRP episodes.
- Categorization of infections into new vs. relapse and monomicrobial vs. polymicrobial.
- Calculation of organism distribution and antimicrobial susceptibility rates.
Main Results:
- Staphylococci were the most common cause of monomicrobial PDRP (44% of new episodes).
- Gram-negative organisms were more prevalent in polymicrobial PDRP (58%).
- Antimicrobial resistance remained stable, but ciprofloxacin resistance in E. coli increased significantly (3% to 24%).
Conclusions:
- Significant differences exist in microbial causes between new and relapse PDRP, and between monomicrobial and polymicrobial infections.
- While overall antimicrobial resistance was stable, specific increases like ciprofloxacin resistance in E. coli warrant attention.
- These findings inform treatment strategies for PD-related peritonitis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Peritoneal Dialysis I: Introduction and Procedure
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection II: Pathophysiology

